The drug in question is abatacept, and it's been part of a trial set up to test its effectiveness and safety.This involved 213 patients at high risk of developing rheumatoid arthritis in the ...

Kevzara is in a group of new rheumatoid arthritis medicines that are intended as successors to established drugs such as AbbVie's Humira (adalimumab) and Johnson & Johnson's Remicade (infliximab ...

Ablynx is looking for new partners to take its rheumatoid arthritis drug vobarilizumab into phase 3 development, after AbbVie turned down an option to license the drug. AbbVie has already paid the ...

The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid ...

Indirect comparative efficacy studies are fraught with difficulties since duration and severity of disease, concomitant medications ... against RA. Monoclonal antibodies and other new agents ...

more aggressive use of DMARDs and new classes of disease-modifying biologic medications that target the specific pathways responsible for RA. The updated 2021 American College of Rheumatology ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Researchers wanted to comprehensively "map" the health outcomes of people using weight-loss drugs. To this end, they compared 175 health outcomes of 215,970 patients using GLP-1 RA drugs with ...

Some biologic drugs for RA come in shots, while others are given as IV infusions. If you get shots, your doctor or nurse can give you injections at the doctor's office. They can teach you how to ...

Rheumatoid arthritis (RA) is a chronic inflammatory disorder that primarily affects the joints, leading to pain and disability. The introduction of biologic drugs has significantly improved ...